Lung cancers attributable to environmental tobacco smoke and air pollution in non-smokers in different European countries: a prospective study
Year: 2007
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Several countries are discussing new legislation on the ban of smoking in public places, and on the acceptable levels of traffic-related air pollutants. It is therefore useful to estimate the burden of disease associated with indoor and outdoor air pollution. METHODS: We have estimated exposure to Environmental Tobacco Smoke (ETS) and to air pollution in never smokers and ex-smokers in a large prospective study in 10 European countries (European Prospective Investigation into Cancer and Nutrition)(N = 520,000). We report estimates of the proportion of lung cancers attributable to ETS and air pollution in this population. RESULTS: The proportion of lung cancers in never- and ex-smokers attributable to ETS was estimated as between 16 and 24%, mainly due to the contribution of work-related exposure. We have also estimated that 5-7% of lung cancers in European never smokers and ex-smokers are attributable to high levels of air pollution, as expressed by NO2 or proximity to heavy traffic roads. NO2 is the expression of a mixture of combustion (traffic-related) particles and gases, and is also related to power plants and waste incinerator emissions. DISCUSSION: We have estimated risks of lung cancer attributable to ETS and traffic-related air pollution in a large prospective study in Europe. Information bias can be ruled out due to the prospective design, and we have thoroughly controlled for potential confounders, including restriction to never smokers and long-term ex-smokers. Concerning traffic-related air pollution, the thresholds for indicators of exposure we have used are rather strict, i.e. they correspond to the high levels of exposure that characterize mainly Southern European countries (levels of NO2 in Denmark and Sweden are closer to 10-20 ug/m3, whereas levels in Italy are around 30 or 40, or higher).Therefore, further reduction in exposure levels below 30 ug/m3 would correspond to additional lung cancer cases prevented, and our estimate of 5-7% is likely to be an underestimate. Overall, our prospective study draws attention to the need for strict legislation concerning the quality of air in Europe.
Source: Environmental Health
Authors: Paolo Vineis, Gerard Hoek, Michal Krzyzanowski, Federica Vigna-Taglianti, Fabrizio Veglia, Luisa Airoldi, Kim Overvad, Ole Raaschou-Nielsen, Francoise Clavel-Chapelon, Jacob Linseisen, Heiner Boeing, Antonia Trichopoulou, Domenico Palli, Vittorio Krogh, Rosario Tumino, Salvatore Panico, H Bas Bueno-De-Mesquita, Petra H Peeters, Eiliv Lund E, Antonio Agudo, Carmen Martinez, Miren Dorronsoro, Aurelio Barricarte, Lluis Cirera, J Ramon Quiros, Goran Berglund, Jonas Manjer, Bertil Forsberg, Nicholas E Day, Tim J Key, Rudolf Kaaks, Rodolfo Saracci, Elio Riboli
Institutions: Imperial College London, Utrecht University, World Health Organization, Institute for Scientific Interchange, Mario Negri Institute for Pharmacological Research, Aalborg University Hospital, Aarhus University Hospital, Danish Cancer Society, Inserm, Institut Gustave Roussy, German Cancer Research Center, German Institute of Human Nutrition, National and Kapodistrian University of Athens, Fondazione IRCCS Istituto Nazionale dei Tumori, University of Naples Federico II, National Institute for Public Health and the Environment, University Medical Center Utrecht, UiT The Arctic University of Norway, Institut Català d'Oncologia, Andalusian School of Public Health, Instituto de Salud Pública de Navarra, Gobierno del Principado de Asturias, Lund University, Umeå University, MRC Mitochondrial Biology Unit, Cancer Research UK, University of Oxford, Centre international de recherche sur le cancer, Istituto di Fisiologia Clinica, National Research Council
Language: English
Subfield: Health, Toxicology and Mutagenesis
Field: Environmental Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,490
Funders: Compagnia di San Paolo, Deutsches Krebsforschungszentrum, Wellcome Trust, Institute for Scientific Interchange, British Heart Foundation, European Commission, Bundesministerium für Bildung und Forschung, Cancerfonden, Associazione Italiana per la Ricerca sul Cancro, Norges Forskningsråd, Deutsche Krebshilfe, Medical Research Council, World Cancer Research Fund, Instituto de Salud Carlos III
Awards: G2068095830, G4517043513, G5866486694
OpenAlex ID: W2139288973
